from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2340c/PE_PGRS39

LFCtreatmentdescriptionclass of inhibitor

-0.486

Amikacinug/mL Amikacintranslation

-0.701

Cap5-10ug/mL Capreomycintranslation

1.148

Rox10-50 ug/mL Roxithromycintranslation

-1.084

SM2-5 ug/mL Streptomycintranslation

-1.151

Tet5-10 ug/mL Tetracyclinetranslation

0.614

Rif0.2-5ug/mL Rifampicintranscription

-0.164

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.432

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

0.285

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.519

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.632

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.601

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.778

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.318

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.653

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.581

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.319

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.995

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.233

KCN5-20 ug/mL Potassium cyaniderespiration

-1.500

NaN30.2-2 mM Sodium aziderespiration

-0.378

Nigericin50 uM Nigericinrespiration

0.787

TRC10-150 ug/mL Triclosanrespiration

0.065

TRZ10-25 ug/mL Thioridazinerespiration

0.804

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.604

menadione6-10 ug/mL Menadionerespiration

-0.093

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.613

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.171

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.917

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.697

NRP_1Non-replicating persistence stage 1dosRassociated

-0.651

Amp0.2mg/mL AmpicillincellWall

-0.545

Cephalexin20-100 ug/mL CephalexincellWall

-0.821

Cerulenin0.32-5 ug/mL CerulenincellWall

0.068

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.395

EMB10-20 ug/mL EthambutolcellWall

-1.100

Eta12-40 ug/mL EthionamidecellWall

-1.132

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.502

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.032

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.706

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.324

BZA0.12 mg/mL BenzamidearomaticAmides

0.250

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.433

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.002

H2O24 mM hydrogen peroxideDNAdamaging

-0.630

Levo10 ug/mL LevofloxacinDNAdamaging

-0.049

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.742

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.402

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.406

UVUV-irradiationDNAdamaging

0.529

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.202

Antimycin12.5-50 ug/mL Antimycin A?

-0.971

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.840

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.931

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.524

PA8240.2-2 ug/mL PA-824?

1.045

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.147

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.086

Verapamil50 uM Verapamil?

-0.672

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.673

methoxatin10-20 ug/mL Methoxatin?